Efficacy and tolerance of gemcitabine-based regimens in elderly patients with advanced pancreatic cancer

被引:0
|
作者
Marechal, Raphael
Demols, Anne
Gay, France
Arvanitakis, Marianna
Hendlisz, Alain
Van Laethem, Jean-Luc
机构
[1] Erasme Univ Hosp, B-1070 Brussels, Belgium
[2] Inst Jules Bordet, B-1000 Brussels, Belgium
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:326 / 326
页数:1
相关论文
共 50 条
  • [31] Paclitaxel-Based Chemotherapy for Advanced Pancreatic Cancer after Gemcitabine-Based Therapy Failure: A Case Series of 5 Patients
    Igarashi, Hisato
    Ito, Tetsuhide
    Hisano, Terumasa
    Fujimori, Nao
    Niina, Yusuke
    Yasuda, Mikihiko
    Kaku, Toyoma
    Matsuo, Susumu
    Oono, Takamasa
    Yoshinaga, Masahiro
    Sakai, Hiroyuki
    Takayanagi, Ryoichi
    CASE REPORTS IN ONCOLOGY, 2011, 4 (03): : 534 - 541
  • [32] Predictors for resectability and survival in locally advanced pancreatic cancer after gemcitabine-based neoadjuvant therapy
    Chao, Ying-Jui
    Sy, Edgar D.
    Hsu, Hui-Ping
    Shan, Yan-Shen
    BMC SURGERY, 2014, 14
  • [33] Meta-analysis of the efficacy between gemcit-abine-alone and gemcitabine-based chemotherapy applied to advanced pancreatic cancer
    宋堃
    ChinaMedicalAbstracts(Surgery), 2012, 21 (01) : 50 - 50
  • [34] Predictors for resectability and survival in locally advanced pancreatic cancer after gemcitabine-based neoadjuvant therapy
    Ying-Jui Chao
    Edgar D Sy
    Hui-Ping Hsu
    Yan-Shen Shan
    BMC Surgery, 14
  • [35] Is concomitant radiotherapy necessary with gemcitabine-based chemotherapy in pancreatic cancer?
    Zhang, Xin
    Huang, He-Jing
    Feng, Dan
    Yang, De-Jun
    Wang, Chang-Ming
    Cai, Qing-Ping
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (46) : 17648 - 17655
  • [36] Folfirinage: Tolerance and efficacy of folfirinox in elderly patients with advanced pancreatic adenocarcinoma
    Baldini, C.
    Escande, A.
    Bouche, O.
    Bourgeois, V.
    Renaut-Vantroys, T.
    Ploquin, A.
    Desauw, C.
    Hebbar, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S196 - S196
  • [37] Inferior Survival of Advanced Pancreatic Cancer Patients Who Received Gemcitabine-Based Chemotherapy but Did Not Participate in Clinical Trials
    Yang, Shih-Hung
    Kuo, Yu-Hsuan
    Tien, Yu-Wen
    Hsu, Chiun
    Hsu, Chih-Hung
    Kuo, Sung-Hsin
    Cheng, Ann-Lii
    ONCOLOGY, 2011, 81 (3-4) : 143 - 150
  • [38] DOCETAXEL-CARBOPLATIN FOR PATIENTS WITH ADVANCED PANCREATIC CANCER PROGRESSING AFTER GEMCITABINE-BASED CHEMOTHERAPY FOLLOWED BY METRONOMIC CAPECITABINE
    Shaltout, Ehab
    Abd El Razek, Eman
    El-Gamal, Ahmed
    ANNALS OF ONCOLOGY, 2012, 23 : 62 - 62
  • [39] Gemcitabine-Based Regional Intra-Arterial Infusion Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma
    Liu, Xiaoyu
    Yang, Xuerong
    Zhou, Guofeng
    Chen, Yi
    Li, Changyu
    Wang, Xiaolin
    MEDICINE, 2016, 95 (11)
  • [40] Treatment of metastatic and/or unresectable pancreatic cancer with gemcitabine-based chemotherapy
    Samelis, GF
    Zografos, G
    Areovimata, A
    Kitsou, V
    Papakostas, P
    ANNALS OF ONCOLOGY, 2005, 16 : 324 - 324